Literature DB >> 28639126

A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [18F]THK5351 and [11C]PIB.

Miho Shidahara1,2, Benjamin A Thomas3,4, Nobuyuki Okamura5, Masanobu Ibaraki6, Keisuke Matsubara6, Senri Oyama7, Yoichi Ishikawa8, Shoichi Watanuki9, Ren Iwata8, Shozo Furumoto8, Manabu Tashiro9, Kazuhiko Yanai10, Kohsuke Gonda7, Hiroshi Watabe11.   

Abstract

PURPOSE: To suppress partial volume effect (PVE) in brain PET, there have been many algorithms proposed. However, each methodology has different property due to its assumption and algorithms. Our aim of this study was to investigate the difference among partial volume correction (PVC) method for tau and amyloid PET study.
METHODS: We investigated two of the most commonly used PVC methods, Müller-Gärtner (MG) and geometric transfer matrix (GTM) and also other three methods for clinical tau and amyloid PET imaging. One healthy control (HC) and one Alzheimer's disease (AD) PET studies of both [18F]THK5351 and [11C]PIB were performed using a Eminence STARGATE scanner (Shimadzu Inc., Kyoto, Japan). All PET images were corrected for PVE by MG, GTM, Labbé (LABBE), Regional voxel-based (RBV), and Iterative Yang (IY) methods, with segmented or parcellated anatomical information processed by FreeSurfer, derived from individual MR images. PVC results of 5 algorithms were compared with the uncorrected data.
RESULTS: In regions of high uptake of [18F]THK5351 and [11C]PIB, different PVCs demonstrated different SUVRs. The degree of difference between PVE uncorrected and corrected depends on not only PVC algorithm but also type of tracer and subject condition.
CONCLUSION: Presented PVC methods are straight-forward to implement but the corrected images require careful interpretation as different methods result in different levels of recovery.

Entities:  

Keywords:  Image processing; Partial volume correction; Tau PET; [18F]THK5351

Mesh:

Substances:

Year:  2017        PMID: 28639126     DOI: 10.1007/s12149-017-1185-0

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  15 in total

1.  PET Image Deblurring and Super-Resolution with an MR-Based Joint Entropy Prior.

Authors:  Tzu-An Song; Fan Yang; Samadrita Roy Chowdhury; Kyungsang Kim; Keith A Johnson; Georges El Fakhri; Quanzheng Li; Joyita Dutta
Journal:  IEEE Trans Comput Imaging       Date:  2019-04-25

2.  Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease.

Authors:  Adam P Mecca; Ming-Kai Chen; Ryan S O'Dell; Mika Naganawa; Takuya Toyonaga; Tyler A Godek; Joanna E Harris; Hugh H Bartlett; Wenzhen Zhao; Emmie R Banks; Gessica S Ni; Kelly Rogers; Jean Dominique Gallezot; Jim Ropchan; Paul R Emery; Nabeel B Nabulsi; Brent C Vander Wyk; Amy F T Arnsten; Yiyun Huang; Richard E Carson; Christopher H van Dyck
Journal:  Neurobiol Aging       Date:  2021-11-20       Impact factor: 4.673

3.  Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11 C]UCB-J.

Authors:  Adam P Mecca; Ryan S O'Dell; Emily S Sharp; Emmie R Banks; Hugh H Bartlett; Wenzhen Zhao; Sylwia Lipior; Nina G Diepenbrock; Ming-Kai Chen; Mika Naganawa; Takuya Toyonaga; Nabeel B Nabulsi; Brent C Vander Wyk; Amy F T Arnsten; Yiyun Huang; Richard E Carson; Christopher H van Dyck
Journal:  Alzheimers Dement       Date:  2022-02-17       Impact factor: 16.655

4.  Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.

Authors:  Adam P Mecca; Nicole M Barcelos; Shuo Wang; Anna Brück; Nabeel Nabulsi; Beata Planeta-Wilson; Jennifer Nadelmann; Amanda L Benincasa; Jim Ropchan; Yiyun Huang; Joel Gelernter; Peter H Van Ness; Richard E Carson; Christopher H van Dyck
Journal:  Neurobiol Aging       Date:  2017-10-06       Impact factor: 4.673

Review 5.  Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.

Authors:  Konstantinos Chiotis; Alessandra Dodich; Marina Boccardi; Cristina Festari; Alexander Drzezga; Oskar Hansson; Rik Ossenkoppele; Giovanni Frisoni; Valentina Garibotto; Agneta Nordberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-15       Impact factor: 9.236

6.  Characterization of point-spread function specification error on Geometric Transfer Matrix partial volume correction in [11C]PiB amyloid imaging.

Authors:  Charles M Laymon; Davneet S Minhas; Sarah K Royse; Howard J Aizenstein; Ann D Cohen; Dana L Tudorascu; William E Klunk
Journal:  EJNMMI Phys       Date:  2021-07-20

7.  Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data.

Authors:  Michael Rullmann; Anke McLeod; Michel J Grothe; Osama Sabri; Henryk Barthel
Journal:  J Nucl Med       Date:  2020-05-01       Impact factor: 11.082

8.  Longitudinal tau PET in ageing and Alzheimer's disease.

Authors:  Clifford R Jack; Heather J Wiste; Christopher G Schwarz; Val J Lowe; Matthew L Senjem; Prashanthi Vemuri; Stephen D Weigand; Terry M Therneau; Dave S Knopman; Jeffrey L Gunter; David T Jones; Jonathan Graff-Radford; Kejal Kantarci; Rosebud O Roberts; Michelle M Mielke; Mary M Machulda; Ronald C Petersen
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

Review 9.  MRI-Driven PET Image Optimization for Neurological Applications.

Authors:  Yuankai Zhu; Xiaohua Zhu
Journal:  Front Neurosci       Date:  2019-07-31       Impact factor: 4.677

Review 10.  In Vivo and In Vitro Characteristics of Radiolabeled Vesamicol Analogs as the Vesicular Acetylcholine Transporter Imaging Agents.

Authors:  Kazuma Ogawa; Kazuhiro Shiba
Journal:  Contrast Media Mol Imaging       Date:  2018-06-13       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.